Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic Enterprisewide Zetia & Vytorin Case Study: Successfully Challenging The Statin Market Datamonitor, Nov 2005, Pages: 13   Description     Table of Contents        Enquire before Buying    Send to a Friend   This case study focuses on the commercial impact of Zetia and Vytorin, which form part of a new drug class that challenge the statin market, and discusses the marketing strategy that has contributed to their success. Customers who bought this item also bought Statin Adjunct Therapy - Zetia, Revenue Protection for Zocor? Lipitor Case Study: Lifecycle Management Strategies Symbicort Case Study: Creating Differentation In Combination Products Roche Case Study: Becoming A Targeted Medicine Player Combivir And Trizivir Case Study: The Role Of Pricing In Achieving Success In Combination Therapies Antidyslipidemics - Cholesterol Absorption of Lipitors Dominance Exposing Search as a Web Services: LifeCare Case Study Realizing Change: Knowing When and How To Successfully Change

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster